Meeder Asset Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,822
Closed -$98K 815
2025
Q2
$98K Sell
3,822
-740
-16% -$21.7K 0.01% 304
2025
Q1
$167K Buy
+4,562
New +$157K 0.01% 255
2024
Q4
Sell
-1,547
Closed -$58.3K 905
2024
Q3
$58.3K Buy
+1,547
New +$59.6K ﹤0.01% 343
2020
Q2
Sell
-93
Closed -$4K 2047
2020
Q1
$4K Buy
+93
New +$4.21K ﹤0.01% 1845
2019
Q2
Sell
-35
Closed -$1K 2029
2019
Q1
$1K Buy
35
+4
+13% +$157 ﹤0.01% 1607
2018
Q4
$1K Buy
+31
New +$1.21K ﹤0.01% 1616
2017
Q2
Sell
-373
Closed -$8K 1647
2017
Q1
$8K Buy
+373
New +$8.43K ﹤0.01% 901

Other funds holding ATEX

Meeder Asset Management's ATEX Position: Q3 2025 in Review

Meeder Asset Management sold out of Anterix (ATEX) in Q3 2025, closing a stake of 3,822 shares — an estimated $98K sold.

Meeder Asset Management first reported a position in ATEX in Q1 2017 and held it in 7 quarters. The position peaked at $167K in Q1 2025. 111 funds tracked by Wall St. Rank hold ATEX as of Q3 2025.

  • Meeder Asset Management reported no remaining Anterix position as of Q3 2025 after selling out during the quarter.
  • Meeder Asset Management sold 3,822 Anterix shares in Q3 2025, an estimated $98K.
  • Meeder Asset Management first reported a position in Anterix in Q1 2017 and held it in 7 quarters.
  • Meeder Asset Management's Anterix position peaked at $167K in Q1 2025.
  • 111 funds tracked by Wall St. Rank held Anterix as of Q3 2025.

Based on Meeder Asset Management's 13F filing for Q3 2025, filed 24 Oct 2025.